Windtree Therapeutics Completes $26.4 Million Private Placement

WARRINGTON, Pa., Dec. 9, 2019 -- (Healthcare Sales & Marketing Network) -- Windtree Therapeutics, Inc. (OTCQB: WINT), a biotechnology and medical device company focused on developing drug product candidates and medical device technologies to address acute... Biopharmaceuticals, Venture Capital Windtree Therapeutics, istaroxime, AEROSURF, rostafuroxin
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news